Established External Evidence
Published research, regulatory documents, validated instruments, and accepted clinical knowledge.
Scientific operating system
Evidence. Precision. Progress. The site is designed to show not only what trūth believes, but why, on what evidence, and with what uncertainty.
Claim discipline
Every scientific statement is visibly assigned to one state so observation, inference, hypothesis, and planned research are not blended together.
Published research, regulatory documents, validated instruments, and accepted clinical knowledge.
Directly documented findings from source records, patient reporting, imaging, or clinician assessment.
A testable explanation that may organize future studies but is not presented as established fact.
A material uncertainty that affects interpretation, feasibility, safety, or regulatory strategy.
A prospective outcome measure selected before data collection and separated from exploratory analysis.
Precise statements concerning company formation, IND status, trial authorization, and product approval.
Decision principles
The company’s scientific and operational identity is built around explicit constraints rather than promotional optimism.
Consent, context, dignity, privacy, and the right to withdraw are design requirements.
A promising observation does not override cardiovascular, hepatic, psychiatric, or interaction risk.
Trials must be able to show that the product or intervention does not work as hypothesized.
Version history, limitations, negative findings, and conflicts remain part of the scientific record.
Publication standard
Public product statement
Neither Belcopa nor NovusClarus is approved, available for sale, or established as safe or effective. The pages describe research concepts and proposed development pathways.
Governance
trūth is assembling an independent scientific, clinical, regulatory, ethics, and operational leadership structure before assigning permanent executive roles.
Advisors must be able to disagree publicly and document material concerns.
Financial, authorship, intellectual-property, and institutional interests are recorded.
Material product and study decisions retain rationale, evidence, dissent, and approval history.